genetique mutation kuvura kanseri y'ibihaha

Gusobanukirwa uruhare rwa genetique mutation kuvura kanseri y'ibihaha ni ngombwa mu gucunga kanseri y'ibihaha yihariye kandi ikora neza. Iyi ngingo iragaragaza uburyo ibizamini bya geneti bimenyesha ibyemezo byo kuvura, ubwoko bwimiterere ihindagurika ikunze kuboneka muri kanseri yibihaha, hamwe nubuvuzi bugamije guhindura ihinduka ry’imiterere yihariye. genetique mutation kuvura kanseri y'ibihaha. Ihinduka rishobora kugaragara muri gen zigenzura imikurire ya selile, kugabana, no gusana. Kumenya ihinduka ry’imihindagurikire ni ngombwa kuko rishobora kuyobora ingamba zo kuvura no kuzamura umusaruro w’abarwayi. Mu kigo cy’ubushakashatsi bwa kanseri ya Shandong Baofa, dushyira imbere gusobanukirwa imiterere yimiterere ya kanseri yibihaha ya buri murwayi.Imihindagurikire ya geneti ni iki?Kuvura kanseri y'ibihaha ni impinduka muburyo bwa ADN zishobora kuganisha ku myitwarire idasanzwe ya selile. Ihinduka rishobora kuragwa cyangwa kuboneka mubuzima bwumuntu. Muri kanseri y'ibihaha, ihinduka ry’imihindagurikire ni rusange kandi akenshi riterwa n’ibidukikije nko kunywa itabi cyangwa guhura n’umwanda. Ihinduka ry’imihindagurikire rishobora guhungabanya imikorere isanzwe ya selile, biganisha ku gukura kutagenzuwe no kubyara ibibyimba. Guhindura ibinyabuzima bisanzwe muri kanseri y'ibihaha. Gusobanukirwa niyi ihinduka ningirakamaro muguhitamo uburyo bwiza bwo kuvura. Dore bimwe mubisanzwe:EGFR (Kwakira Epidermal Growth Factor Receptor): Guhinduka kwa EGFR bikunze kugaragara muri kanseri y'ibihaha itari ntoya (NSCLC), cyane cyane muri adenocarcinoma. Ihinduka rishobora gutuma kanseri ya kanseri yunvikana nubuvuzi runaka bugamije.ALK (Anaplastique Lymphoma Kinase): ALK ivugurura ni iyindi ntego ihinduka ihinduka muri NSCLC. ALK inhibitor yerekanye intsinzi ikomeye mukuvura ibibyimba niyi mutation.ROS1: Kimwe na ALK, ROS1 fusion irashobora gutuma kanseri yibihaha ikura. Inhibitori ya ROS1 irahari kubarwayi bafite ROS1-nziza ya NSCLC.BRAF: Guhinduka kwa BRAF, cyane cyane ihinduka rya V600E, urashobora kubisanga muri NSCLC. Inzitizi ya BRAF irashobora gukoreshwa muguhindura ihinduka.KRAS: Ihinduka rya KRAS risanzwe muri adenocarcinoma y'ibihaha. Mugihe amateka atoroshye kuyareba, havuka uburyo bushya bwo kuvura kanseri yibihaha ya KRAS.PD-L1 (Gahunda Yurupfu-Ligand 1): Nubwo atari ihinduka rya gene muburyo busanzwe, imvugo ya PD-L1 ni biomarker ishobora guhanura igisubizo cyikingira. Imvugo ndende ya PD-L1 irashobora kwerekana ko umurwayi ashobora kungukirwa nubudahangarwa. Kwipimisha rusange kuri Kanseri yibihahaKuvura kanseri y'ibihaha igaragazwa hifashishijwe ibizamini bya genetike byuzuye, bizwi kandi nka biomarker test cyangwa molekile profiling. Ubu bushakashatsi bwasesenguye ibibyimba cyangwa rimwe na rimwe, urugero rwamaraso kugirango hamenyekane ihinduka ry’imiterere itera kanseri ikura. Ibisubizo by'ibi bizamini bifasha abahanga mu kuvura indwara ya oncologue kwihitiramo gahunda yo kuvura kugira ngo bagaragaze ibimenyetso byihariye bya buri murwayi wa kanseri. Ikigo cy’ubushakashatsi bwa kanseri ya Baofa gikoresha ikoranabuhanga rigezweho rya tekinoroji yo gupima. Ubwoko bwibizamini bya geneti Ubwoko butandukanye bwibizamini bya geneti bukoreshwa mugupima kanseri y'ibihaha no gutegura gahunda yo kuvura:Ibihe bizakurikiraho (NGS): NGS nuburyo bwuzuye bwo gupima bushobora gusesengura icyarimwe icyarimwe. Ibi bituma habaho gutahura ibintu byinshi byahinduwe hamwe nibindi byahinduwe.Urunigi rwa Polymerase (PCR): PCR nuburyo bwibanze bwo kwipimisha bukoreshwa mugutahura ihinduka ryimiterere cyangwa gene ihinduka.Fluorescence Muri Hybridisation ya Situ (AMAFI): AMAFI akoreshwa mugushakisha imiterere ya gene, nka ALK na ROS1.Immunohistochemie (IHC): IHC ikoreshwa mugutahura imvugo ya poroteyine, nka PD-L1, ishobora gufasha guhanura igisubizo kijyanye no gukingira indwara. Ni ryari Ikizamini cya Geneti gikwiye gukorwa? Kwipimisha geneti bigomba gukorwa ku barwayi bose basuzumwe na NSCLC yateye imbere. Kwipimisha bigomba gukorwa hakiri kare bishoboka mugutegura gahunda yo kuvura kugirango imiti igamije gusuzumwa kuva mbere. Ni ngombwa kandi kongera gusuzuma niba kanseri itera imbere cyangwa niba uburyo bushya bwo kuvura buboneka.Ubuvuzi bugenewe Kanseri y'ibihaha Ubuvuzi bugamije ni imiti yibasira cyane kanseri ya kanseri. genetique mutation kuvura kanseri y'ibihaha. Ubu buryo bwo kuvura bugamije kubangamira imikurire, kugabana, no gukwirakwiza kanseri ya kanseri mu gihe bigabanya kwangirika kw ingirabuzimafatizo zisanzwe. Ubuvuzi bwa Baofa bwihariye bwubuvuzi bukoresha uburyo bugezweho bwo kuvura.Ibikoresho bya EGFR Inhibitor yaEGFR ikoreshwa mu kuvura kanseri y'ibihaha hamwe na mutation ya EGFR. Iyi miti ihagarika ibikorwa bya poroteyine ya EGFR, ikunze kuba idakabije mu ngirabuzimafatizo za kanseri hamwe n'ihinduka. Inzitizi zisanzwe za EGFR zirimo:Gefitinib (Iressa)Erlotinib (Tarceva)Afatinib (Gilotrif)Osimertinib (Tagrisso): Akenshi kuvura umurongo wa mbere kuri EGFR-yahinduwe na NSCLC. Iyi miti ihagarika ibikorwa bya poroteyine ya ALK, ikunze gukora mu buryo budasanzwe mu ngirabuzimafatizo za kanseri hamwe no guhinduranya ibintu. Ibisanzwe ALK inhibitor zirimo:Crizotinib (Xalkori)Alectinib (Alecensa)Ceritinib (Zykadia)Brigatinib (Alunbrig)Lorlatinib (Lorbrena)ROS1 InhibitorROS1 inhibitor zikoreshwa mukuvura kanseri yibihaha hamwe na ROS1. Iyi miti ihagarika ibikorwa bya poroteyine ya ROS1, ikunze gukora mu buryo budasanzwe mu ngirabuzimafatizo za kanseri hamwe na hamwe. Ibisanzwe ROS1 inhibitor zirimo:Crizotinib (Xalkori)Entrectinib (Rozlytrek)Inhibitor ya BRAF Inhibitor ya BRAF ikoreshwa mu kuvura kanseri y'ibihaha hamwe na mutation ya BRAF, cyane cyane ihinduka rya V600E. Iyi miti ihagarika ibikorwa bya poroteyine ya BRAF, ikunze kuba idakabije mu ngirangingo za kanseri hamwe na mutation. Inzitizi rusange za BRAF zirimo:Dabrafenib (Tafinlar)Trametinib (Mekinist): Akenshi ikoreshwa ifatanije na dabrafenib.KRAS G12C InhibitorSotorasib (Lumakras) na Adagrasib (Krazati) ni ingero za inhibitori za KRAS G12C zikoreshwa mukuvura kanseri yibihaha hamwe na mutation yihariye ya KRAS. Bakora bahagarika ibikorwa bya poroteyine ya KRAS ihindagurika.Immunotherapy na Genetic MutationsImmunotherapy ni ubwoko bwa kanseri ifasha umubiri w’umubiri kurwanya kanseri. Mugihe ubudahangarwa bw'umubiri butareba neza genetique mutation kuvura kanseri y'ibihaha, ihinduka ryimiterere ya genetike hamwe na biomarkers, nka imvugo ya PD-L1 hamwe nuburemere bwibibyimba (TMB), birashobora guhanura igisubizo kijyanye no gukingira indwara. Abarwayi bafite imvugo ndende ya PD-L1 cyangwa TMB ndende barashobora kungukirwa nubudahangarwa. Mu kigo cy’ubushakashatsi bwa kanseri ya Shandong Baofa, duhuza immunotherapie n’ubundi buryo bwo kuvura kugira ngo habeho uburyo bunoze. Ejo hazaza h’ubuvuzi bwa kanseri y'ibihaha Umwanya wo kuvura kanseri y'ibihaha uratera imbere byihuse. Ubuvuzi bushya bugamije kuvura hamwe nubudahangarwa burimo gutezwa imbere no kugeragezwa mubigeragezo byamavuriro. Abashakashatsi nabo barimo gukora kugirango bamenye ibishya genetique mutation kuvura kanseri y'ibihaha ibyo birashobora kwibasirwa nubuvuzi bushya. Mugihe dusobanukiwe genetiki ya kanseri yibihaha igenda itera imbere, turashobora kwitega kubona uburyo bwihariye bwo kuvura abarwayi. Ikigo cy’ubushakashatsi cya Kanseri ya Shandong Baofa cyiyemeje kuguma ku isonga ry’iri terambere. Imbonerahamwe yerekana: Ubuvuzi bugamije bushingiye kuri MutationMutationTargeted TherapiesDescriptionEGFROsimertinib, Gefitinib, Erlotinib, AfatinibBlock EGFR protein proteinALKAlectinib, Crizotinib, Brigatinib, Ceritinib, ibikorwaROS1Crizotinib, EntrectinibGufungura ibikorwa bya poroteyine ROS1BRAF V600EDabrafenib (akenshi hamwe na Trametinib) Hagarika ibikorwa bya poroteyine BRAF KRAS G12CSotorasib, AdagrasibBlock yahinduye ibikorwa bya poroteyine ya KRASUmwanzuro Gusobanukirwa uruhare rwa genetique mutation kuvura kanseri y'ibihaha ni ngombwa mu kunoza ibisubizo ku barwayi ba kanseri y'ibihaha. Igeragezwa rya genetike rirashobora gufasha kumenya ihinduka ryihariye rishobora kwibasirwa nubuvuzi bwihariye. Mugihe dusobanukiwe genetiki ya kanseri yibihaha ikomeje kwiyongera, turashobora kwitegereza kubona uburyo bunoze kandi bugamije kuvura iyi ndwara yangiza. Sura Shandong Baofa Ikigo Cyubushakashatsi Kanseri kugirango umenye byinshi kubyerekeranye nuburyo bwuzuye bwo kuvura kanseri y'ibihaha.Inshingano: Aya makuru agamije intego zuburezi gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ugisha inama inzobere mu by'ubuzima zujuje ibisabwa kugira ngo zisuzume kandi zivure indwara. Ibyerekeye Ikigo cya Kanseri. www.cancer.govUmuryango w'Abanyamerika. www.cancer.org